Biscado enters India's beta-blocker therapy space, addressing the growing burden of heart disease
Cadila Pharmaceuticals launches Biscado (Bisoprolol) for cardiovascular disease management in India
Biscado (Bisoprolol) For Cardiovascular Disease M | 11/06/2025 | By Darshana | 108
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy